Sumalpong, Arselyn N.

HRN: 28-93-10  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2026
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
04/30/2026
05/07/2026
PO
3ml
Qid
Oral Candidiasis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: